Characterization of Structural Features Controlling the Receptiveness of Empty Class II MHC Molecules

MHC class II molecules (MHC II) play a pivotal role in the cell-surface presentation of antigens for surveillance by T cells. Antigen loading takes place inside the cell in endosomal compartments and loss of the peptide ligand rapidly leads to the formation of a non-receptive state of the MHC molecule. Non-receptiveness hinders the efficient loading of new antigens onto the empty MHC II. However, the mechanisms driving the formation of the peptide inaccessible state are not well understood. Here, a combined approach of experimental site-directed mutagenesis and computational modeling is used to reveal structural features underlying “non-receptiveness.” Molecular dynamics simulations of the human MHC II HLA-DR1 suggest a straightening of the α-helix of the β1 domain during the transition from the open to the non-receptive state. The movement is mostly confined to a hinge region conserved in all known MHC molecules. This shift causes a narrowing of the two helices flanking the binding site and results in a closure, which is further stabilized by the formation of a critical hydrogen bond between residues αQ9 and βN82. Mutagenesis experiments confirmed that replacement of either one of the two residues by alanine renders the protein highly susceptible. Notably, loading enhancement was also observed when the mutated MHC II molecules were expressed on the surface of fibroblast cells. Altogether, structural features underlying the non-receptive state of empty HLA-DR1 identified by theoretical means and experiments revealed highly conserved residues critically involved in the receptiveness of MHC II. The atomic details of rearrangements of the peptide-binding groove upon peptide loss provide insight into structure and dynamics of empty MHC II molecules and may foster rational approaches to interfere with non-receptiveness. Manipulation of peptide loading efficiency for improved peptide vaccination strategies could be one of the applications profiting from the structural knowledge provided by this study.

[1]  Andreas Schlundt,et al.  Bidirectional binding of invariant chain peptides to an MHC class II molecule , 2010, Proceedings of the National Academy of Sciences.

[2]  D. Wiley,et al.  The human class II MHC protein HLA-DR1 assembles as empty alpha beta heterodimers in the absence of antigenic peptide. , 1992, Cell.

[3]  A. Sant,et al.  Cutting edge: a single, essential hydrogen bond controls the stability of peptide-MHC class II complexes. , 1999, Journal of immunology.

[4]  Christian Freund,et al.  Small Organic Compounds Enhance Antigen Loading of Class II Major Histocompatibility Complex Proteins by Targeting the Polymorphic P1 Pocket*♦ , 2006, Journal of Biological Chemistry.

[5]  G. Hämmerling,et al.  How HLA-DM edits the HLA-DR:peptide repertoire , 1997 .

[6]  A. Sant,et al.  Energetic asymmetry among hydrogen bonds in MHC class II⋅peptide complexes , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[7]  D. Fremont,et al.  Mutations changing the kinetics of class II MHC peptide exchange. , 2001, Immunity.

[8]  N Srinivasan,et al.  Stereochemical modeling of disulfide bridges. Criteria for introduction into proteins by site-directed mutagenesis. , 1989, Protein engineering.

[9]  G. Hämmerling,et al.  Editing of the HLA‐DR‐peptide repertoire by HLA‐DM. , 1996, The EMBO journal.

[10]  A. Sarai,et al.  Contribution of a Single Hydrogen Bond between βHis81 of MHC Class II I‐Ek and the Bound Peptide to the pH‐Dependent Thermal Stability , 2004, Microbiology and immunology.

[11]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[12]  J. Gorski,et al.  Cutting Edge: HLA-DM–Mediated Peptide Exchange Functions Normally on MHC Class II–Peptide Complexes That Have Been Weakened by Elimination of a Conserved Hydrogen Bond , 2009, The Journal of Immunology.

[13]  Matthew W. Anderson,et al.  Cooperativity during the formation of peptide/MHC class II complexes. , 2005, Biochemistry.

[14]  George T Detitta,et al.  Thermofluor-based high-throughput stability optimization of proteins for structural studies. , 2006, Analytical biochemistry.

[15]  D. Wiley,et al.  The human class II MHC protein HLA-DR1 assembles as empty αβ heterodimers in the absence of antigenic peptide , 1992, Cell.

[16]  J. Strominger,et al.  Conformational Variation of Surface Class II MHC Proteins during Myeloid Dendritic Cell Differentiation Accompanies Structural Changes in Lysosomal MIIC1 , 2005, The Journal of Immunology.

[17]  Bernd Rupp,et al.  Anchor Side Chains of Short Peptide Fragments Trigger Ligand-Exchange of Class II MHC Molecules , 2008, PloS one.

[18]  J. Strominger,et al.  Extracellular antigen processing and presentation by immature dendritic cells. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  L. Stern,et al.  Empty and peptide-loaded class II major histocompatibility complex proteins produced by expression in Escherichia coli and folding in vitro. , 1999, Protein expression and purification.

[20]  E. Unanue,et al.  In Autoimmune Diabetes Unique Autoreactive T Cells Recognize Insulin Peptides Generated in the Islets of Langerhans , 2010, Nature Immunology.

[21]  Don C. Wiley,et al.  Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide , 1994, Nature.

[22]  S. Ceman,et al.  Late events in the intracellular sorting of major histocompatibility complex class II molecules are regulated by the 80‐82 segment of the class II β chain , 1997, European journal of immunology.

[23]  S. Sadegh-Nasseri,et al.  Stable peptide binding to MHC class II molecule is rapid and is determined by a receptive conformation shaped by prior association with low affinity peptides. , 1999, Journal of immunology.

[24]  P. van Endert,et al.  A chaperone-assisted high yield system for the production of HLA-DR4 tetramers in insect cells. , 2004, Journal of immunological methods.

[25]  D. Weber,et al.  Cutting Edge: HLA-DM Functions through a Mechanism That Does Not Require Specific Conserved Hydrogen Bonds in Class II MHC-Peptide Complexes1 , 2009, The Journal of Immunology.

[26]  Michelle Palmer,et al.  Monoclonal Antibodies Specific for the Empty Conformation of HLA-DR1 Reveal Aspects of the Conformational Change Associated with Peptide Binding* , 2004, Journal of Biological Chemistry.

[27]  Martin Zacharias,et al.  Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study. , 2009, Biopolymers.

[28]  G. Benedek,et al.  Determinants of the Peptide-induced Conformational Change in the Human Class II Major Histocompatibility Complex Protein HLA-DR1* , 2000, The Journal of Biological Chemistry.

[29]  L. Stern,et al.  Probing the ligand-induced conformational change in HLA-DR1 by selective chemical modification and mass spectrometric mapping. , 2005, Biochemistry.

[30]  G. Benedek,et al.  A conformational change in the human major histocompatibility complex protein HLA-DR1 induced by peptide binding. , 1999, Biochemistry.

[31]  M. Vrljic,et al.  Formation of a highly peptide-receptive state of class II MHC. , 1998, Immunity.

[32]  L. Mitschang,et al.  A xenon-129 biosensor for monitoring MHC-peptide interactions. , 2009, Angewandte Chemie.

[33]  A. Sant,et al.  Energetics and cooperativity of the hydrogen bonding and anchor interactions that bind peptides to MHC class II protein. , 2005, Journal of molecular biology.

[34]  J. Strominger,et al.  Superactivation of an immune response triggered by oligomerized T cell epitopes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Kedar Narayan,et al.  HLA-DM targets the hydrogen bond between the histidine at position β81 and peptide to dissociate HLA-DR–peptide complexes , 2007, Nature Immunology.

[36]  Anthony Cruz,et al.  Model for the Peptide-Free Conformation of Class II MHC Proteins , 2008, PloS one.

[37]  Gerrit Groenhof,et al.  GROMACS: Fast, flexible, and free , 2005, J. Comput. Chem..

[38]  L. Glimcher,et al.  Structural mutation affecting intracellular transport and cell surface expression of murine class II molecules , 1988, The Journal of experimental medicine.

[39]  Leah M. Octavio,et al.  Empty Class II Major Histocompatibility Complex Created by Peptide Photolysis Establishes the Role of DM in Peptide Association* , 2007, Journal of Biological Chemistry.

[40]  S. Ceman,et al.  Individual hydrogen bonds play a critical role in MHC class II:peptide interactions: implications for the dynamic aspects of class II trafficking and DM‐mediated peptide exchange , 1999, Immunological reviews.

[41]  Wilfried Bardet,et al.  Real-time measurement of in vitro peptide binding to soluble HLA-A*0201 by fluorescence polarization. , 2004, Biochemistry.

[42]  L. Santambrogio,et al.  The lymph as a pool of self-antigens. , 2011, Trends in immunology.

[43]  E. Unanue,et al.  Conformational isomers of a peptide–class II major histocompatibility complex , 2005, Immunological reviews.

[44]  Philip J Norris,et al.  A hairpin turn in a class II MHC-bound peptide orients residues outside the binding groove for T cell recognition. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Ira Mellman,et al.  Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.